GenPath
487 Edward H Ross Dr
Elmwood Park, NJ 07407
1 800 627 1479


© 2009 GenPath is a business unit of BioReference Laboratories, Inc.

Chronic Lymphocytic Leukemia (CLL) Panel



Test Name Chronic Lymphocytic Leukemia (CLL) Panel
Also Known As CLL Panel (+12, p53, D13s319, ATM)
Panel? Yes
Clinical Utility and/or Limitations Trisomy 12 (+12) is found in about 20% of CLL/SLL cases and is usually associated with an unfavorable response to chemotherapy and a predominantly unmutated IgVH gene status. D13s319- Deletions involving 13q14 are detectable by FISH in approximately 50% of persons with CLL. This deletion is associated with a favorable clinical outcome. ATM (11q22) Mutations of the ataxia-telangiectasia gene are seen in 10-20% of B-cell CLL and are associated with a relatively aggressive disease course and poorer prognosis. p53 (17p13) monosomy is usually associated with an unfavorable response to chemotherapy.
Diagnosis Under Consideration CLL Prognosis
Method FISH
 
Ordering Details
Test Code 5280-3
Assay Schedule Mon - Sat, daily
Turnaround Time 24-72hr Turnaround
Preferred Specimen and Volume 2 mL Heparinized or EDTA Marrow, 5 mL Heparinized or EDTA Blood or Fresh Tissue in RPMI.
Alternate Specimen and Volume Non- decalcified Paraffin Embedded Tissue ( block)
 
Specimen Handling Information
Specimen Storage Refrigerate fresh specimen until shipping, ship within 24 hrs.
Specimen Transport Ship specimen with ice pack.
Causes For Specimen Rejection No patient ID on Specimen, Patient ID on specimen and Requisition doesn't match, incorrect fixative (tube/solution), Specimen without GenPath/BioReference requisition. Frozen specimen.
 
Billing Information
CPT Codes 88368 (4)